TMCnet1h
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Merck & Co (MRK) Investors To Inquire About Securities Fraud Class Action
On July 30, 2024, Merck released its second quarter 2024 financial report and disclosed a significant reduction in Gardasil vaccinations, resulting in an overabundance of inventory at Merck's Chinese ...
3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Columbia Dividend Income Fund Q4 2024 Commentary
Institutional Class shares of Columbia Dividend Income Fund returned -1.34% for Q4 2024. Click here to read the full ...
Columbia Dividend Opportunity Fund Q4 2024 Commentary
Columbia Dividend Opportunity Fund Institutional Class shares returned -1.55% for Q4 2024. Click here to read the full ...
Investing Snacks10h
Merck Faces Challenges, But 2025 Offers Investment Opportunity
Merck‘s performance in 2025 started rough due to weaker-than-expected results, despite surpassing Wall Street estimates with ...
Le Lézard8h
The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK
The Gross Law Firm issues the following notice to shareholders of Merck & Co., Inc. . Shareholders who purchased shares of MRK ...